ESSEN, Germany—Evonik Industries A.G. released its financial results for 2014, with profits and sales coming in close to 2013 levels.
The firm's net income decreased 1 percent while its sales showed an increase of 2 percent to about $14.3 billion. The German specialty chemical company's adjusted EBITDA dropped to about $2.11 billion.
Sales in Evonik's Specialty Chemicals Segment was on a par with 2013, at about $1.18 billion, while the segment's adjusted EBITDA showed a 3 percent drop to about $105.5 million in 2014.
Evonik said it holds an optimistic outlook for 2015, expecting to report slightly higher sales and a slightly higher adjusted earnings compared to 2014.
Klaus Engel, chairman of the executive board, also announced that the company intended to continue its growth strategy. The firm invested $1.22 billion in new production facilities, including about $466 million at its German sites.
In September 2014. Evonik opened a new 20,000-ton expansion at its precipitated silica site in Chester, Pa., while making another undisclosed investment in silica capacity expansion in Ako, Japan.
The expansions are part of Evonik's initiative to increase worldwide capacities for precipitated silica by 30 percent.